MUCOSAL IMMUNOL
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q1 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 免疫学 Immunology | SCIE | Q1 | 45/183 |
75.4%
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 免疫学 Immunology | SCIE | Q1 | 27/156 JCI 1.26 |
83.3%
|
Mucosal Immunology is a leading peer-reviewed journal dedicated to advancing the understanding of the immune system as it operates at mucosal surfaces, including the gastrointestinal, respiratory, urogenital, and ocular tracts. Published by Springer Nature on behalf of the Society for Mucosal Immunology, the journal serves as a premier platform for research on the interface between host immunity and the diverse microbial, dietary, and environmental challenges encountered at these critical barriers. Its scope encompasses fundamental and translational studies on epithelial barrier function, innate and adaptive immune regulation, microbiota-host interactions, vaccine development, and the pathogenesis of mucosal inflammatory diseases such as inflammatory bowel disease, asthma, and celiac disease. The journal publishes a range of article types, including original research articles, comprehensive reviews, brief communications, and technical reports, alongside occasional editorials and meeting highlights. Its target audience includes immunologists, microbiologists, gastroenterologists, pulmonologists, and infectious disease researchers, as well as clinicians and biotechnologists focused on mucosal therapeutics. Notably, Mucosal Immunology offers both subscription and open access options, allowing authors to choose a publishing route that maximizes dissemination. With an Impact Factor of 5.500 (2026) and a consistent ranking in the Q1 quartile of the Immunology category, the journal is recognized as a top-tier, authoritative resource in its specialized field, reflecting high citation impact and rigorous peer review standards that attract cutting-edge work from leading laboratories worldwide.